Receive up-to-the-minute news updates on the hottest topics with NewsHub. Install now.

Sanofi to pay Regeneron $462 million in revised immuno-oncology deal

January 7, 2019 5:25 PM
90 0

PARIS (Reuters) - Sanofi will pay Regeneron some $462 million in a revision of their deal in immuno-oncology, a growing sector in healthcare research which aims to help the body’s own immune system fight cancer.

The two companies said the new arrangement would give France’s Sanofi increased flexibility to advance its early-stage immuno-oncology pipeline, while U.S. healthcare group Regeneron retains all rights to its other immuno-oncology discovery and development programmes.

Read more

Share in social networks:

Comments - 0